In the issue of March 2023, the magazine PLATINUM “Aziende & Protagonisti”, attached to the Italian financial newspaper Il Sole 24 Ore, features a...
The new European research project NeuroCOV aims to investigate neurological and neuropsychological complications due to COVID-19. These include a compromised sense of smell and taste, impaired ability to concentrate, memory problems, stroke, and significant brain scan alterations among COVID-19 patients across all ages and independent of COVID-19 severity.
The impact of this new emerging pandemic, also called NeuroCOVID, is immense, and society and healthcare systems are at risk of unprecedented consequences. With a multidisciplinary and international consortium of 10 institutions, NeuroCOV strives to enhance the medical predicaments of developing NeuroCOVID, advance monitoring and treatment, as well as address the societal consequences of this major global problem.